Cardiac-specific block of miR-22-3p biogenesis or inhibition of target gene ACSL4 activation may be a novel effective therapeutic avenue to block exosome-mediated pathological communications between MI heart and tumor tissue. Here, ACSL4 is linked to myocardial infarction.